New report published by Global Info Research which offers insights on the global Artificial Pancreas Devices Systems market.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Click to view the full report TOC, figure and tables:
Global Artificial Pancreas Devices Systems Market: Forecast by Type / Application / Region
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a “closed-loop” system, an “automated insulin delivery” system, or an “autonomous system for glycemic control.”
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The major players in global Artificial Pancreas Devices Systems market include: Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed.
On the basis of product, the Artificial Pancreas Devices Systems market is primarily split into: Threshold Suspended Device Systems, Hybrid Closed-loop APDS and Other Systems.
On the basis on the end users/applications covers: Hospitals and Clinics.
In the last several years, global market of artificial pancreas devices systems developed rapidly, with an average growth rate of 10%. In 2017, global revenue of artificial pancreas devices systems is nearly 55 M USD; the actual consumption is about 6900 units.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Artificial Pancreas Devices Systems Market 2018 Forecast to 2023
Europe Artificial Pancreas Devices Systems Market 2018 Forecast to 2023
North America Artificial Pancreas Devices Systems Market 2018 Forecast to 2023
Asia-Pacific Artificial Pancreas Devices Systems Market 2018 Forecast to 2023
China Artificial Pancreas Devices Systems Market 2018 Forecast to 2023
EMEA Artificial Pancreas Devices Systems Market 2018 Forecast to 2023
Global Artificial Pancreas Devices Systems Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong